Current investigations into retatrutide, a dual activator for GLP-1 and GIP receptors, are showing promising outcomes in treating weight gain and related 2 diabetes. Animal data suggest a novel action contributing to https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/